Such a relationship is suggested by unpublished data from Bogunia-Kubik and colleagues, which showed higher rates of GVHD in recipients with the high VDR activity (aa) genotype treated with supplementary vitamin D [4]. This evidence concerns the gene VDR and graft versus host disease.